|
시장보고서
상품코드
2050660
소화기계 의약품 시장 : 약제 유형별, 제형별, 질환별, 유통 채널별, 지역별Gastroenterology Market, By Drug Type, By Dosage Form, By Disease Type, By Distribution Channel, By Geography |
||||||
소화기 질환 치료제 시장은 2026년에 398억 달러로 추정되고 있으며, 2033년까지 618억 달러에 달할 것으로 예상되고 있습니다. 2026-2033년에는 CAGR 6.5%로 성장할 것으로 전망되고 있습니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 398억 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년 예측 기간의 CAGR : | 6.50% | 2033년 시장 규모 예측 : | 618억 달러 |
세계의 소화기 질환 시장의 성장은 위궤양, 염증성장질환, 과민성 대장 증후군과 같은 소화기 질환의 증가와 효과적인 진단 및 치료 솔루션을 필요로 하는 고령 인구의 증가에 의해 주도되고 있습니다. 또한 소화기 내시경 장비의 기술 발전과 소화기 질환을 위한 신약 개발도 시장 성장을 촉진하는 요인으로 작용하고 있습니다. 많은 시장 기업이 의료 시설과 환자의 증가하는 요구에 부응하기 위해 신제품 출시와 사업 확장에 힘쓰고 있습니다. 고가의 소화기 내시경 장비에 따른 높은 비용과 저소득 국가에서의 낮은 인지도는 더 많은 환자들이 의료 서비스를 받는 데 있으며, 장애요인이 될 수 있습니다.
시장 역학:
세계 소화기 질환의 유병률 증가, 소화기 질환에 취약한 고령 인구의 증가, 소화기 의료기기의 발전 등의 요인이 세계 소화기 시장 성장을 촉진하고 있습니다. 그러나 소화기용 기기 및 내시경 장비에 따른 높은 비용은 시장 성장을 저해할 수 있습니다. 소화기 질환을 위한 새로운 경구용 의약품의 등장과 신흥 국가의 헬스케어 인프라 구축은 시장 확대를 위한 유망한 기회로 작용할 수 있습니다. 북미는 방대한 환자 수, 혁신적인 치료법의 신속한 승인, 시장 기업의 전략적 노력으로 세계 소화기 질환 시장을 독점하고 있습니다. 그러나 중국, 인도 등의 국가에서 전문 의료에 대한 접근성이 개선됨에 따라 아시아태평양은 높은 성장이 예상됩니다.
(본 조사의 주요 특징):
세계의 소화기 질환 시장에 대해 조사분석했으며, 2025년을 기준연도로 하여 예측 기간(2026-2033년) 시장 규모(10억 달러)와 연평균 성장률(CAGR)을 조사하여 전해드립니다.
이 보고서는 각 부문의 잠재적 매출 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
또한 이 보고서는 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략에 대한 중요 인사이트도 제공합니다.
이 연구는 다음과 같은 매개 변수를 기반으로 세계의 소화기병학 시장의 주요 기업을 프로파일링합니다. 구체적으로 기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적 및 전략 등입니다.
조사 대상 주요 기업으로는 Medtronic, Johnson & Johnson, Abbott Laboratories, Hoffmann-La Roche, Bayer AG, GlaxoSmithKline, Sanofi, Pfizer, Novartis AG 등이 포함됩니다.
이 보고서는 각 기업의 마케팅 담당자와 경영진이 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략과 관련하여 정보에 입각한 의사결정을 내릴 수 있도록 돕습니다.
세계의 소화기병학 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
이해관계자들은 글로벌 소화기병학 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 소화기계 의약품 시장 : 약제 유형별, 2021-2033년
제5장 세계의 소화기계 의약품 시장 : 제형별, 2021-2033년
제6장 세계의 소화기계 의약품 시장 : 질환 유형별, 2021-2033년
제7장 세계의 소화기계 의약품 시장 : 유통 채널별, 2021-2033년
제8장 세계의 소화기계 의약품 시장 : 지역별, 2021-2033년
제9장 경쟁 구도
제10장 애널리스트의 제안
제11장 조사 방법
KSA 26.06.10Gastroenterology Market is estimated to be valued at USD 39.80 Bn in 2026 and is expected to reach USD 61.80 Bn by 2033, growing at a compound annual growth rate (CAGR) of 6.5% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 39.80 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 6.50% | 2033 Value Projection: | USD 61.80 Bn |
Global gastroenterology market growth is driven by rising gastrointestinal disorders such as stomach ulcer, inflammatory bowel disease, irritable bowel syndrome and growing geriatric population that requires effective diagnosis and treatment solutions. Furthermore, technological advancements in gastrointestinal endoscopy devices along with development of novel drugs for gastrointestinal issues can also drive the market growth. Various market players are engaged in new product launches and expansions to cater to increasing needs of healthcare facilities as well as patients. High costs associated with advanced gastroenterology devices and lack of awareness in low-income nations can pose challenges for broader patient access to care.
Market Dynamics:
Global gastroenterology market growth is driven by factors like growing prevalence of gastrointestinal disorders worldwide, increasing geriatric population susceptible to digestive diseases, and advancements in gastrointestinal medical devices. However, high costs associated with gastrointestinal instrumentation and endoscopy devices can hamper the market growth. Emergence of novel oral medicines for gastrointestinal issues and developing healthcare infrastructure in emerging nations can present lucrative opportunities for market expansion. North America dominates the global gasteroenterology market, owing to sizable patient population, fast approval of innovative therapies, and strategic initiatives by market players. However, Asia Pacific is expected to offer high growth prospects due to improving access to specialty care in nations like China and India.
(Key features of the study):
This report provides in-depth analysis of the global gastroenterology market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2026-2033), considering 2025 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global gastroenterology market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Medtronic, Johnson & Johnson, Abbott Laboratories, Hoffmann-La Roche, Bayer AG, GlaxoSmithKline, Sanofi, Pfizer, and Novartis AG
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global gastroenterology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global gastroenterology market
Detailed Segmentation-
- By Drug Type Insights (Revenue, USD Bn, 2021 - 2033)
- Biologics/Biosimilars
- Antacids
- Laxatives
- Antidiarrheal Agents
- Antiemetics
- Antiulcer Agents
- Others
- By Dosage Form Insights (Revenue, USD Bn, 2021 - 2033)
- Oral
- Parenteral
- Others
- By Disease Type Insights (Revenue, USD Bn, 2021 - 2033)
- Inflammatory Bowel Diseases (IBD)
- Crohn's Disease
- Ulcerative Colitis
- Irritable Bowel Syndrome (IBS)
- Gastroesophageal Reflux Disease (GERD)
- Liver Diseases
- Colorectal Cancer
- Others (Peptic Ulcers, etc.)
- By Distribution Channel Insights (Revenue, USD Bn, 2021 - 2033)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Allied Digestive Health
- Boston Scientific
- Capital Digestive Care
- CRH Medical
- Iterative Scopes
- Fujifilm Medical
- Gastro Health
- GI Alliance
- Medtronic
- Micro-Tech Endoscopy
- Motus GI
- Olympus
- One GI
- PE GI Solutions
- Peak Gastroenterology Associates
- Pentax Medical
- Pinnacle GI Partners
- Saneso
- Surgical Innovations
- Wision A.I.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Drug Type
- Market Snapshot, By Dosage Form
- Market Snapshot, By Disease Type
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Gastroenterology Market, By Drug Type, 2021 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Biologics/Biosimilars
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Antacids
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Laxatives
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Antidiarrheal Agents
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Antiemetics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Antiulcer Agents
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
5. Global Gastroenterology Market, By Dosage Form, 2021 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Oral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Parenteral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Global Gastroenterology Market, By Disease Type, 2021 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Inflammatory Bowel Diseases (IBD)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Crohn's Disease
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Ulcerative Colitis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Irritable Bowel Syndrome (IBS)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Gastroesophageal Reflux Disease (GERD)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Liver Diseases
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Colorectal Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others (Peptic Ulcers, etc.)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
7. Global Gastroenterology Market, By Distribution Channel, 2021 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
8. Global Gastroenterology Market, By Region, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Bn)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Company Profiles
- Allied Digestive Health
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Boston Scientific
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Capital Digestive Care
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- CRH Medical
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Iterative Scopes
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Fujifilm Medical
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Gastro Health
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- GI Alliance
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Medtronic
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Micro-Tech Endoscopy
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Motus GI
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Olympus
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- One GI
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- PE GI Solutions
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Peak Gastroenterology Associates
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Pentax Medical
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Pinnacle GI Partners
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Saneso
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Surgical Innovations
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Wision A.I.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Allied Digestive Health
10. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. Research Methodology
- References
- Research Methodology
- About us and Sales Contact
